Avram Hershko

A High-Flying Start to 2023 for GO7

Retrieved on:

Thursday, April 13, 2023

LONDON and MIAMI and TEL AVIV, Israel, April 13, 2023 /PRNewswire/ -- GO7, a travel technology company committed to helping travel brands transform their operations by putting power back into their hands, has had a very active start to 2023. From the new brand launch in January and the structuring of the GO7 leadership team to the expansion of client relationships with regional and global airlines, GO7 has embarked on its inaugural year with significant growth and industry-wide impact.

Key Points:

From the new brand launch in January and the structuring of the GO7 leadership team to the expansion of client relationships with regional and global airlines, GO7 has embarked on its inaugural year with significant growth and industry-wide impact.
"GO7 was built to move fast and innovate with agility, and that's exactly what we've done in the first quarter of this year," says Meir Hadassi Turner, CEO of GO7.
In January, the former 777 Travel officially became GO7, a brand dedicated to re-architecting traditional airline solutions and transforming travel.
For more information about GO7 and the company's Q1 results or to speak with company executives, please contact Vanessa Horwell at [email protected] .

Global Travel Technology Company GO7 Announces CEO and Grows Leadership Team

Retrieved on:

Tuesday, February 14, 2023

TEL, W2, WorldTicket, Turner, Data science, Avram Hershko, Research, Product Development Technologies, Air travel, Management, Airline, Retail, Travel

MIAMI and LONDON and TEL AVIV, Israel, Feb. 14, 2023 /PRNewswire/ -- GO7, a travel technology company committed to transforming travel brands by putting power back into their hands, has announced the appointment of Meir Hadassi Turner as Chief Executive Officer and Yossi Hershko as Chief Technology and Product Officer. The two executives join an experienced and growing team of over 100 employees representing 23 nationalities and 731 collective years of travel industry experience.

Key Points:

They are responsible, alongside the GO7 leadership team, for achieving the brand's core mission of unencumbering airlines and travel brands from conventional approaches to technology and the travel experience.
Meir Hadassi Turner was named CEO of GO7 following a 16-year tenure as founder and CEO of AeroCRS, an innovative Tel Aviv-based travel technology company that became part of 777 Travel (now GO7) in 2022.
"As the new leader of GO7, I am thrilled to be working alongside such a talented, creative and diverse team of individuals.
To learn more about GO7's leadership team or to speak with a company executive, please contact Vanessa Horwell at [email protected] (+1.305-749-5342 ext.

Global Travel Technology Company GO7 Announces CEO and Grows Leadership Team

Retrieved on:

Tuesday, February 14, 2023

TEL, W2, WorldTicket, Turner, Data science, Avram Hershko, Research, Product Development Technologies, Air travel, Management, Airline, Retail, Travel

MIAMI and LONDON and TEL AVIV, Israel, Feb. 14, 2023 /PRNewswire/ -- GO7, a travel technology company committed to transforming travel brands by putting power back into their hands, has announced the appointment of Meir Hadassi Turner as Chief Executive Officer and Yossi Hershko as Chief Technology and Product Officer. The two executives join an experienced and growing team of over 100 employees representing 23 nationalities and 731 collective years of travel industry experience.

Key Points:

They are responsible, alongside the GO7 leadership team, for achieving the brand's core mission of unencumbering airlines and travel brands from conventional approaches to technology and the travel experience.
Meir Hadassi Turner was named CEO of GO7 following a 16-year tenure as founder and CEO of AeroCRS, an innovative Tel Aviv-based travel technology company that became part of 777 Travel (now GO7) in 2022.
"As the new leader of GO7, I am thrilled to be working alongside such a talented, creative and diverse team of individuals.
To learn more about GO7's leadership team or to speak with a company executive, please contact Vanessa Horwell at [email protected] (+1.305-749-5342 ext.

OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board

Retrieved on:

Monday, January 11, 2021

Learned societies, Science and technology awards, Nobel laureates, Israeli Jews, Aaron Ciechanover, Lasker Award, Nobel Prize, Avram Hershko

BINYAMINA, Israel, Jan. 11, 2021 /PRNewswire/ -- OncoHost , global leader in host response profiling for improved personalized cancer therapy, announced today that renowned biologist and winner of The Nobel Prize in Chemistry , Professor Aaron Ciechanover, has joined the company's scientific advisory board.

Key Points:

BINYAMINA, Israel, Jan. 11, 2021 /PRNewswire/ -- OncoHost , global leader in host response profiling for improved personalized cancer therapy, announced today that renowned biologist and winner of The Nobel Prize in Chemistry , Professor Aaron Ciechanover, has joined the company's scientific advisory board.
His profound scientific knowledge in protein biology and fundamental discoveries in protein turnover that awarded him the 2004 Nobel Prize in Chemistry will be an invaluable contribution to our research efforts in identifying effective personalized cancer treatments," said Dr. Ofer Sharon, CEO of OncoHost.
Among the many accolades that Prof. Ciechanover has been awarded are the 2000 Albert Lasker Prize for Basic Medical Research, the 2003 Israel Prize for Biological Research, and the 2004 Nobel Prize in Chemistry.
OncoHost combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy.

Nobel Laureate, Oramed SAB member Prof. Avram Hershko and Oramed CSO Dr. Miriam Kidron to be Featured on Biotalknology Webinar "Oral Delivery of Therapeutic Proteins - Oramed Story" on November 18, 2020

Retrieved on:

Thursday, November 12, 2020

Science and technology awards, Nobel laureates, Israeli Jews, Science and technology in Israel, Avram Hershko, Oramed

Prof. Hershko is a member of the Oramed Scientific Advisory Board.

Key Points:

Prof. Hershko is a member of the Oramed Scientific Advisory Board.
ET, in the conclusion of a two-part webinar series, the session will focus on the "Oral Delivery of Therapeutic Proteins - Oramed Story".
Oramed Pharmaceuticalsis a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection.
Established in 2006, with offices inNew YorkandIsrael, Oramed has developed a novel Protein Oral Delivery (POD) technology.

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

Retrieved on:

Friday, February 15, 2019

Articles, Health sciences, Learned societies, Israeli Jews, Avram Hershko, Paul L. Modrich, Pharmacogenomics, Forensic science, Technion – Israel Institute of Technology, American Academy of Forensic Sciences

The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.

Key Points:

The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.
Three Nobel Lectures will be given by prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Paul Modrich (Duke University).
During ISABS 2019 Conference we will envision the power and advances of personalized medicine that will createsignificantvalue for the healthcare system.
International Society for Applied Biological Sciences (ISABS) is the Association of the American Academy of Forensic Sciences and a leading society in forensic, anthropologicgenetics and personalized medicine.

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

Retrieved on:

Friday, February 15, 2019

Science and technology in Israel, Israeli Jews, Science, Health, Avram Hershko, Paul L. Modrich, Technion – Israel Institute of Technology, Pharmacogenomics, Forensic science, American Academy of Forensic Sciences, Max Planck Society

The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.

Key Points:

The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.
Three Nobel Lectures will be given by prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Paul Modrich (Duke University).
During ISABS 2019 Conference we will envision the power and advances of personalized medicine that will createsignificantvalue for the healthcare system.
International Society for Applied Biological Sciences (ISABS) is the Association of the American Academy of Forensic Sciences and a leading society in forensic, anthropologicgenetics and personalized medicine.